Ajanta Pharma Limited — Pioglitazone Exporter Profile
Indian Pharmaceutical Exporter · #5 for Pioglitazone · $1.8M export value · DGFT Verified
Ajanta Pharma Limited is the #5 Indian exporter of Pioglitazone with $1.8M in export value and 36 verified shipments. Ajanta Pharma Limited holds a 4.7% market share in Pioglitazone exports across 2 countries. The company exports 37 pharmaceutical products worth $116.1M across 17 therapeutic categories.
Ajanta Pharma Limited — Pioglitazone Export Profile: Buyers & Destinations
Where Does Ajanta Pharma Limited Export Pioglitazone?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $735.9K | 16 | 52.0% |
| IRAQ | $679.9K | 20 | 48.0% |
Ajanta Pharma Limited exports Pioglitazone to 2 countries. The largest destination is PHILIPPINES accounting for 52.0% of Ajanta Pharma Limited's Pioglitazone shipments. These destinations reflect Ajanta Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Pioglitazone from Ajanta Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AJANTA PHARMA PHILIPPINES INC | PHILIPPINES | $735.9K | 16 |
| HAWKARY PHARMACEUITCAL CO.* | IRAQ | $378.0K | 11 |
| AL-THURAYA SCIENTIFIC DRUG BUREAU | IRAQ | $131.4K | 4 |
| HAWKARY PHARMACEUITCAL CO | IRAQ | $74.9K | 2 |
| SHAMS AL-THURAYA CO FOR GENERAL TRA | IRAQ | $46.1K | 1 |
| SHAMS AL THURAYA CO FOR GENERAL TRA | IRAQ | $27.1K | 1 |
| SHAMS AL-THURAYA CO FOR GENERAL | IRAQ | $22.4K | 1 |
Ajanta Pharma Limited supplies Pioglitazone to 7 buyers globally. The largest buyer is AJANTA PHARMA PHILIPPINES INC (PHILIPPINES), followed by HAWKARY PHARMACEUITCAL CO.* (IRAQ) and AL-THURAYA SCIENTIFIC DRUG BUREAU (IRAQ). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Pioglitazone Export Value and How Much Does Ajanta Pharma Limited Contribute?
India exported $35.2M worth of Pioglitazone through 2,674 shipments from 115 suppliers to 70 countries, serving 293 buyers globally. Ajanta Pharma Limited contributes $1.8M to this total, accounting for 4.7% of India's Pioglitazone exports. Ajanta Pharma Limited ships Pioglitazone to 2 countries through 7 buyers.
What Is the Average Shipment Value for Ajanta Pharma Limited's Pioglitazone Exports?
Ajanta Pharma Limited's average Pioglitazone shipment value is $48.9K per consignment, based on 36 shipments totaling $1.8M. The largest destination is PHILIPPINES (52.0% of Ajanta Pharma Limited's Pioglitazone exports).
How Does Ajanta Pharma Limited Compare to Other Indian Pioglitazone Exporters?
Ajanta Pharma Limited ranks #5 among 115 Indian Pioglitazone exporters with a 4.7% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($15.2M), AUROBINDO PHARMA LIMITED ($4.0M), INTAS PHARMACEUTICALS LIMITED ($3.4M). Ajanta Pharma Limited processed 36 shipments to 2 destination countries.
What Pioglitazone Formulations Does Ajanta Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ASENZA PLUS 15/2 MG TABLETS[12600PACKx3x10=378000TABS]PIOGLITAZONE AND GLIMEPIRIDE TAB]EACH UNCOATED TAB CONT:AS PER INV | $100.0K | 2 |
| ASENZA PLUS 30/2 MG TABLETS[12060PACKx3x10=361800TABS]PIOGLITAZONE AND GLIMEPIRIDE TAB]EACH UNCOATED TAB CONT:AS PER INV | $100.0K | 2 |
| SHIPMENT UNDER CONSIGNMENTSALE:GLYDYL M15/500MG TABLETS[13355 X 3 X 10 = 400650TABLETS][PIOGLITAZONE AND METFORMIN HYD | $81.4K | 3 |
| ASENZA PLUS 30/2 MG TABS[12960PACKx3x10=388800 TABS][PIOGLITAZONE AND GLIMEPIRIDE TABS]EACH UNCOATED TAB CONT:AS PER INV | $50.0K | 1 |
| ASENZA PLUS 15/2 MG TABS[13020PACKx3x10=390600TABS][PIOGLITAZONE AND GLIMEPIRIDETABS]EACH UNCOATED TABS CONT:AS PER INV | $50.0K | 1 |
| TIBAN P 20/30 TABLETS [TENELIGLIPTIN 20MG AND PIOGLITAZONE 30 MG TABLETS] [6465X 3 X 10 = 193950 TABLETS] CONT AS PERNOS | $50.0K | 1 |
| ASENZA PLUS 30/2 MG TABS[12595PACKx3x10=377850 TABS][PIOGLITAZONE AND GLIMEPIRIDE TABS] [EACH UNCOATED TABLET AS PER INV | $50.0K | 1 |
| ASENZA PLUS 15/2 MG TABS[12295PACKx3x10=368850 TABS][PIOGLITAZONE AND GLIMEPIRIDE TAB]EACH UNCOATED TABS CONT:AS PER INV | $50.0K | 1 |
| TENELIZONE TABLETS 20/30 MG [12840 PACKX3X10=385200 TABS](TENELIGLIPTIN 20MG & PIOGLITAZONE 30MG TABLETS) AS PER INVOICENOS | $50.0K | 1 |
| TIBAN P 20/30 TABLETS[TENELIGLIPTIN 20 MG AND PIOGLITAZONE 30 MG TABLETS] [6375X 3 X 10=191250TABLETS]CONT AS PER INVOINOS | $50.0K | 1 |
Ajanta Pharma Limited exports 32 distinct Pioglitazone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ASENZA PLUS 15/2 MG TABLETS[12600PACKx3x10=378000TABS]PIOGLI with 2 shipments worth $100.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Ajanta Pharma Limited Compare to Nearest Pioglitazone Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | INTAS PHARMACEUTICALS LIMITED | $3.4M | 473 | 11 | $7.2K |
| 4 | MACLEODS PHARMACEUTICALS LTD | $3.3M | 311 | 2 | $10.7K |
| 5 | AJANTA PHARMA LIMITED ★ | $1.8M | 36 | 2 | $48.9K |
| 6 | MICRO LABS LIMITED | $1.6M | 98 | 9 | $15.9K |
| 7 | IND SWIFT LIMITED | $1.2M | 55 | 8 | $22.2K |
Ajanta Pharma Limited ranks #5 among 115 Indian Pioglitazone exporters. Average shipment value of $48.9K compared to the market average of $305.7K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and MACLEODS PHARMACEUTICALS LTD.
Which Indian Ports Ship Pioglitazone Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR | 249 | 9.3% |
| HYDERABAD ICD | 229 | 8.6% |
| DELHI AIR CARGO ACC (INDEL4) | 206 | 7.7% |
| SAHAR AIR | 205 | 7.7% |
| HYDERABAD ICD (INSNF6) | 203 | 7.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 143 | 5.3% |
| MUNDRA SEA | 127 | 4.7% |
| CMA CGM LOGISTICS PARK ICD | 126 | 4.7% |
What Other Diabetes & Endocrine Products Does Ajanta Pharma Limited Export?
Ajanta Pharma Limited also exports these diabetes & endocrine products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Ajanta Pharma Limited's Pioglitazone Exports
Ajanta Pharma's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The ongoing Israel-Iran conflict has disrupted shipping lanes in the Red Sea, leading to increased freight costs and extended delivery timelines. Such disruptions pose challenges for Indian pharmaceutical exporters like Ajanta, necessitating adaptive logistics strategies to maintain supply chain integrity. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their foothold in the American market. India's pharmaceutical exports to the US surged by 74% in March 2025, indicating a shift in sourcing preferences. Ajanta Pharma can leverage this trend by emphasizing its compliance with stringent US regulatory standards and offering competitive pricing. (business-standard.com)
In the European Union, adherence to the Falsified Medicines Directive (FMD) is paramount. Indian exporters, including Ajanta, must ensure robust serialization and traceability measures to comply with these regulations. Non-compliance could result in restricted market access, underscoring the importance of investing in advanced tracking systems and quality assurance protocols.
Ajanta Pharma Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA, WHO, and EU GMP setting stringent compliance benchmarks. India has made significant strides in this arena, surpassing the US in the number of FDA-registered generic manufacturing sites, boasting 752 FDA-approved facilities as of 2024. (business-standard.com) Ajanta Pharma's commitment to quality is evident in its adherence to these international standards, facilitating smoother market entry and bolstering its reputation among global stakeholders.
About Ajanta Pharma Limited
Ajanta Pharma Limited exports 37 products worth $116.1M. Beyond Pioglitazone, top products include Artemether, Amlodipine, Clopidogrel, Rosuvastatin, Montelukast. View the complete Ajanta Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pioglitazone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Pioglitazone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Ajanta Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 36 individual customs records matching Ajanta Pharma Limited exporting Pioglitazone, covering 32 formulations to 2 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 70+ countries, 293+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Pioglitazone Export Data from Ajanta Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Ajanta Pharma Limited's Pioglitazone exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Ajanta Pharma Limited
Full Company Profile →
37 products · $116.1M total trade · 17 categories
Pioglitazone Stats
Company Overview
Top Products by Ajanta Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Ajanta Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pioglitazone. For current shipment-level data, contact TransData Nexus.